亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding

医学 肝性脑病 胃肠病学 内科学 门脉高压 重症监护医学 肝硬化
作者
Fatima Higuera‐de la Tijera,A. Servín-Caamaño,Francisco Salas-Gordillo,José Luis Pérez-Hernández,Juan Miguel Abdo-Francis,J. Camacho-Aguilera,S.N. Alla,Fiacro Jiménez-Ponce
出处
期刊:Canadian Journal of Gastroenterology & Hepatology [Pulsus Group]
卷期号:2018: 1-10 被引量:47
标识
DOI:10.1155/2018/3015891
摘要

Background and Aim. Variceal bleeding is the second most important precipitating factor related to the development of episodic hepatic encephalopathy; but to date there are no recommendations to prevent this complication. The aim of this study was to compare if primary prophylaxis with lactulose or L-ornithine L-aspartate or rifaximin, in cirrhotic patients with variceal bleeding, is better than placebo for avoiding the development of hepatic encephalopathy. Methods. A randomized, double-blind, placebo-controlled clinical trial (ClinicalTrials.gov identifier: NCT02158182) which included cirrhotic patients with variceal bleeding, without minimal or clinical hepatic encephalopathy at admission. Findings. 87 patients were randomized to one of four groups. The basal characteristics were similar between groups. Comparatively with placebo, the frequency with regard to the development of hepatic encephalopathy was as follows: lactulose (54.5% versus 27.3%; OR = 0.3, 95% CI 0.09-1.0; P = 0.06); L-ornithine L-aspartate (54.5% versus 22.7%, OR = 0.2, 95% CI 0.06-0.88; P = 0.03); rifaximin (54.5% versus 23.8%; OR = 0.3, 95% CI 0.07-0.9; P = 0.04). There was no significant difference between the three groups receiving any antiammonium drug (P = 0.94). In the group receiving lactulose, 59.1% had diarrhea, and 45.5% had abdominal discomfort, bloating, and flatulence. Two patients (10%) treated with lactulose and a patient (4.5%) in the placebo group developed spontaneous bacterial peritonitis due to E. coli; one of them died due to recurrent variceal bleeding. There were no other adverse effects. Conclusions. Antiammonium drugs, particularly L-ornithine L-aspartate and rifaximin, proved to be effective in preventing the development of hepatic encephalopathy in those cirrhotic patients with variceal bleeding.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sissiarno发布了新的文献求助50
2秒前
sissiarno发布了新的文献求助50
2秒前
sissiarno发布了新的文献求助50
2秒前
3秒前
小单完成签到 ,获得积分10
7秒前
diligent完成签到,获得积分10
8秒前
13秒前
李云昊完成签到 ,获得积分10
17秒前
343123完成签到,获得积分10
19秒前
huang完成签到,获得积分10
21秒前
22秒前
泥豪泥嚎完成签到,获得积分10
23秒前
25秒前
科研通AI6.4的应助被甘乐采纳,获得10
28秒前
28秒前
感动沛容发布了新的文献求助10
29秒前
彩色南烟完成签到,获得积分10
33秒前
顺利的谷菱完成签到,获得积分10
33秒前
的速度发布了新的文献求助10
34秒前
可久斯基完成签到 ,获得积分10
36秒前
斯文钢笔发布了新的文献求助10
36秒前
打打的应助被A2311采纳,获得10
40秒前
沉默岩完成签到,获得积分10
41秒前
43秒前
44秒前
萧雨墨发布了新的文献求助30
47秒前
柳贯一发布了新的文献求助10
47秒前
47秒前
A2311发布了新的文献求助10
48秒前
碳烤小肥羊完成签到 ,获得积分10
49秒前
易28完成签到,获得积分10
50秒前
huang发布了新的文献求助10
51秒前
54秒前
55秒前
余香的应助被无奈诗槐采纳,获得10
58秒前
paradox完成签到 ,获得积分10
1分钟前
suyongye关注了科研通微信公众号
1分钟前
嘻嘻哈哈的应助被科研通管家采纳,获得10
1分钟前
1分钟前
fairytaler的应助被科研通管家采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190060
求助须知:如何正确求助?哪些是违规求助? 9577165
关于积分的说明 21851884
捐赠科研通 7788155
什么是DOI,文献DOI怎么找? 3436233
关于科研通互助平台的介绍 2559935
邀请新用户注册赠送积分活动 2482792